Acadian Asset Management
CGEM icon

Acadian Asset Management’s Cullinan Oncology CGEM Stock Holding History

Acadian Asset Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-81,721
Closed -$618K – 1676
2025
Q1 		$618K Buy
+81,721
New +$784K ﹤0.01% 1039
2024
Q4 		– Sell
-956
Closed -$16K – 1697
2024
Q3 		$16K Buy
+956
New +$17K ﹤0.01% 2002
2023
Q1 		– Sell
-16,927
Closed -$178K – 1763
2022
Q4 		$178K Sell
16,927
-9,974
-37% -$121K ﹤0.01% 1309
2022
Q3 		$344K Buy
+26,901
New +$362K ﹤0.01% 1090

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Acadian Asset Management's CGEM Position: Q2 2025 in Review

Acadian Asset Management sold out of Cullinan Oncology (CGEM) in Q2 2025, closing a stake of 81,721 shares — an estimated $618K sold.

Acadian Asset Management first reported a position in CGEM in Q3 2022 and held it in 4 quarters. The position peaked at $618K in Q1 2025. 143 funds tracked by Wall St. Rank hold CGEM as of Q2 2025.

  • Acadian Asset Management reported no remaining Cullinan Oncology position as of Q2 2025 after selling out during the quarter.
  • Acadian Asset Management sold 81,721 Cullinan Oncology shares in Q2 2025, an estimated $618K.
  • Acadian Asset Management first reported a position in Cullinan Oncology in Q3 2022 and held it in 4 quarters.
  • Acadian Asset Management's Cullinan Oncology position peaked at $618K in Q1 2025.
  • 143 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2025.

Based on Acadian Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.